XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Sales, net $ 27,091,064 $ 11,639,586 $ 49,867,126 $ 29,167,950
Cost of sales        
Total cost of sales 13,262,559 7,871,727 28,834,441 19,978,415
Gross profit 13,828,505 3,767,859 21,032,685 9,189,535
Operating expenses        
Sales and marketing 1,160,412 1,007,831 3,148,290 2,862,991
Research and development 134,575 134,919 399,367 377,881
General and administrative 2,185,980 1,646,685 5,696,901 4,816,214
Total operating expenses 3,480,967 2,789,435 9,244,558 8,057,086
Income from operations 10,347,538 978,424 11,788,127 1,132,449
Interest and other income (loss) (87,483) 91,105 881,316 292,476
Interest expense (36,124) (40,701) (105,959) (130,085)
Income before income taxes 10,223,931 1,028,828 12,563,484 1,294,840
Provision (benefit) for income taxes 1,598,180 4,394 (151,153) 7,875
Net income 8,625,751 1,024,434 12,714,637 1,286,965
Preferred Stock dividend requirements (145,535) (175,456) (493,826) (527,162)
Deemed contribution on extinguishment of preferred stock 2,525,848 0 2,519,124 0
Income applicable to common shareholders $ 11,006,064 $ 848,978 $ 14,739,935 $ 759,803
Basic earnings per share $ 0.33 $ 0.03 $ 0.45 $ 0.02
Diluted earnings per share $ 0.33 $ 0.03 $ 0.45 $ 0.02
Weighted average common shares outstanding:        
Basic (in shares) 33,371,471 32,674,954 32,947,241 32,671,648
Diluted (in shares) 33,984,934 32,674,954 33,071,652 32,671,648
Costs of manufactured product        
Cost of sales        
Total cost of sales $ 11,580,674 $ 6,935,269 $ 25,331,916 $ 17,450,038
Royalty expense to shareholder        
Cost of sales        
Total cost of sales $ 1,681,885 $ 936,458 $ 3,502,525 $ 2,528,377